Direkt zum Inhalt
Merck
  • Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring.

Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring.

Genome medicine (2015-03-13)
Taotao Lao, Kimberly Glass, Weiliang Qiu, Francesca Polverino, Kushagra Gupta, Jarrett Morrow, John Dominic Mancini, Linh Vuong, Mark A Perrella, Craig P Hersh, Caroline A Owen, John Quackenbush, Guo-Cheng Yuan, Edwin K Silverman, Xiaobo Zhou
ZUSAMMENFASSUNG

The HHIP gene, encoding Hedgehog interacting protein, has been implicated in chronic obstructive pulmonary disease (COPD) by genome-wide association studies (GWAS), and our subsequent studies identified a functional upstream genetic variant that decreased HHIP transcription. However, little is known about how HHIP contributes to COPD pathogenesis. We exposed Hhip haploinsufficient mice (Hhip (+/-) ) to cigarette smoke (CS) for 6 months to model the biological consequences caused by CS in human COPD risk-allele carriers at the HHIP locus. Gene expression profiling in murine lungs was performed followed by an integrative network inference analysis, PANDA (Passing Attributes between Networks for Data Assimilation) analysis. We detected more severe airspace enlargement in Hhip (+/-) mice vs. wild-type littermates (Hhip (+/+) ) exposed to CS. Gene expression profiling in murine lungs suggested enhanced lymphocyte activation pathways in CS-exposed Hhip (+/-) vs. Hhip (+/+) mice, which was supported by increased numbers of lymphoid aggregates and enhanced activation of CD8+ T cells after CS-exposure in the lungs of Hhip (+/-) mice compared to Hhip (+/+) mice. Mechanistically, results from PANDA network analysis suggested a rewired and dampened Klf4 signaling network in Hhip (+/-) mice after CS exposure. In summary, HHIP haploinsufficiency exaggerated CS-induced airspace enlargement, which models CS-induced emphysema in human smokers carrying COPD risk alleles at the HHIP locus. Network modeling suggested rewired lymphocyte activation signaling circuits in the HHIP haploinsufficiency state.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Zitronensäure, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
Zitronensäure, ACS reagent, ≥99.5%
Sigma-Aldrich
Zitronensäure, ≥99.5%, FCC, FG
Sigma-Aldrich
Zitronensäure, 99%
Sigma-Aldrich
Zitronensäure, anhydrous, suitable for cell culture, suitable for plant cell culture
Supelco
Citronensäure, wasserfrei, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Natriumzitrat, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Zitronensäure, BioUltra, anhydrous, ≥99.5% (T)
USP
Zitronensäure, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Zitronensäure, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Sigma-Aldrich
2-Hydroxybuttersäure, 97%
Sigma-Aldrich
Zitrat-konzentrierte Lösung -Lösung, BioReagent, suitable for coagulation assays, 4 % (w/v)
Sigma-Aldrich
Zitrat-konzentrierte Lösung -Lösung, BioUltra, Molecular Biology, 1 M in H2O
Supelco
Zitronensäure, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Zitronensäure, anhydrous, European Pharmacopoeia (EP) Reference Standard